Detection of exonic copy-number changes in genes associated with rare neurodevelopmental disorders using an oligonucleotide-based comparative genomic hybridization-array method
Copy number variations (CNVs) have been well documented to contribute significantly to some genetic disorders; however their frequency is currently not well established in many rare conditions. Here we describe the development, validation and clinical implementation of a custom oligonucleotide-based array CGH platform for the detection of exonic deletions and duplications in 54 genes, primarily implicated in neurodevelopmental disorders, for which our laboratory currently offers clinical sequence analysis.

